Stock & Company Details
Heron Therapeutics Inc $HRTX
Price:
N/A
N/A
190M
$63M
52 Week High:
N/A
10 Day Average Volume:
N/A
-1.85
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
HRTX technical indicators
Latest Heron Therapeutics Inc (HRTX) indicator readings as of 2026-08-28.
HRTX's 14-day RSI is 36.8, in neutral territory. At $0.33 it is trading 63.9% below its 200-day moving average of $0.90, and below its 50-day average of $0.42. Price sits in the middle of its Bollinger Bands ($0.21 to $0.52). ADX reads 31.5, indicating a trending market.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of SUSTOL, ZYNRELEF, and CINVANTI. Its pipeline product is HTX-011.
Finance Bot
Ask your questions
Start by typing a question below.
